NDC 0187-0004 – Siliq
Brodalumab 210 mg/1 · Injection · Subcutaneous
Product NDC0187-0004
Product details
- Brand name
- Siliq
- Generic name
- Brodalumab
- Labeler
- Bausch Health US LLC
- Dosage form
- Injection
- Route
- Subcutaneous
- Marketing category
- BLA · BLA761032
- Marketed since
- February 15, 2017
- Listing expires
- December 31, 2027
- Pharmacologic class
- Interleukin-17 Receptor A Antagonist
Active ingredients
- Brodalumab 210 mg/1
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 0187-0004-02 | 2 SYRINGE in 1 CARTON (0187-0004-02) / 1 INJECTION in 1 SYRINGE (0187-0004-00) | Feb 15, 2017 |
| 0187-0004-03 sample | 2 INJECTION in 1 CARTON (0187-0004-03) | Jun 1, 2026 |
| 0187-0004-04 sample | 1 INJECTION in 1 SYRINGE (0187-0004-04) | Jun 1, 2026 |